Journal of Thrombosis and Haemostasis, 1538-7933

Tidskrift

Fler filtreringsmöjligheter
  1. Artikel i vetenskaplig tidskrift
  2. New functional test for the TFPIα cofactor activity of Protein S working in synergy with FV-Short

    Björn Dahlbäck, Guo, L. J., Bengt Zöller & Tran, S., 2019, I : Journal of Thrombosis and Haemostasis. 17, 4, s. 585-595

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. Genome-wide analysis of genetic determinants of circulating factor VII-activating protease (FSAP) activity

    Olsson, M., Stanne, T. M., Pedersen, A., Lorentzen, E., Kara, E., Martinez-Palacian, A., Rønnow Sand, N. P., Jacobsen, A. F., Sandset, P. M., Sidelmann, J. J., G. Engström, O. Melander, Kanse, S. M. & Jern, C., 2018, I : Journal of Thrombosis and Haemostasis. 16, 10, s. 2024-2034

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  4. Effect of late prophylaxis in hemophilia on joint status: A randomized trial

    Manco-Johnson, M. J., B. Lundin, Funk, S., Peterfy, C., Raunig, D., Werk, M., Kempton, C. L., Reding, M. T., Goranov, S., Gercheva, L., Rusen, L., Uscatescu, M. V., Pierdominici, M., Engelen, S., Pocoski, J., Walker, D. & Hong, W., 2017 nov, I : Journal of Thrombosis and Haemostasis. 15, 11, s. 2115-2124

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. Intensity of factor VIII treatment and the development of inhibitors in non-severe hemophilia A patients: Results of the INSIGHT case-control study

    van Velzen, A. S., Eckhardt, C. L., Peters, M., Leebeek, F. W. G., Escuriola-Ettingshausen, C., Hermans, C., Keenan, R. D., J. Astermark, Male, C., Peerlinck, K., le Cessie, S., Van der Bom, J. G. & Fijnvandraat, K., 2017 jul 3, I : Journal of Thrombosis and Haemostasis. 15, 7, s. 1422-1429

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. Novel insights into the regulation of coagulation by factor V isoforms, tissue factor pathway inhibitorα, and protein S

    B. Dahlbäck, 2017 jul 1, I : Journal of Thrombosis and Haemostasis. 15, 7, s. 1241-1250 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. Prospective study of thromboembolism in 1038 children with acute lymphoblastic leukemia - a Nordic Society of Pediatric Hematology and Oncology (NOPHO) study.

    Tuckuviene, R., Ranta, S., Albertsen, B. K., Andersson, N. G., Bendtsen, M. D., Frisk, T., Gunnes, M. W., Helgestad, J., Heyman, M. M., Jonsson, O. G., Mäkipernaa, A., Pruunsild, K., Ulf Tedgård, Trakymiene, S. S. & Ruud, E., 2016, I : Journal of Thrombosis and Haemostasis. 14, 3, s. 485-494

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  8. Population Pharmacokinetics of Plasma-Derived Factor IX: Procedures for Dose Individualization.

    Brekkan, A., Erik Berntorp, Jensen, K., Nielsen, E. I. & Jönsson, S., 2016, I : Journal of Thrombosis and Haemostasis. 14, 4, s. 724-732

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. The lectin complement pathway serine proteases (MASPs) represent a possible crossroad between the coagulation and complement systems in thromboinflammation.

    Kozarcanin, H., Lood, C., Munthe-Fog, L., Sandholm, K., Hamad, O. A., Anders Bengtsson, Skjoedt, M-O., Huber-Lang, M., Garred, P., Ekdahl, K. N. & Nilsson, B., 2016, I : Journal of Thrombosis and Haemostasis. 14, 3, s. 531-545

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  10. Measuring factor IX activity of nonacog beta pegol with commercially available one-stage clotting and chromogenic assay kits: A two-center study

    Bowyer, A. E., A. Hillarp, Ezban, M., Persson, P. & Kitchen, S., 2016, I : Journal of Thrombosis and Haemostasis. 14, 7, s. 1428-1435

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. Prophylaxis Escalation in Severe von Willebrand Disease: A Prospective Study from the von Willebrand Disease Prophylaxis Network.

    Abshire, T., Cox-Gill, J., Kempton, C. L., Leebeek, F. W. G., Carcao, M., Kouides, P., Donfield, S. & Erik Berntorp, 2015, I : Journal of Thrombosis and Haemostasis. 13, 9, s. 1585-1589

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  12. Effects of recombinant human prothrombin on thrombin generation in plasma from patients with haemophilia A and B.

    Hansson, K. M., Gustafsson, D., Skärby, T., Frison, L. & Erik Berntorp, 2015, I : Journal of Thrombosis and Haemostasis. 13, 7, s. 1293-1300

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. The Fc gamma receptor IIa R131H polymorphism is associated with inhibitor development in severe hemophilia A

    Eckhardt, C. L., Jan Astermark, Nagelkerke, S. Q., Geissler, J., Tanck, M. W. T., Peters, M., Fijnvandraat, K. & Kuijpers, T. W., 2014, I : Journal of Thrombosis and Haemostasis. 12, 8, s. 1294-1301

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  14. Elevated risk of venous but not arterial thrombosis in Waldenstrom macroglobulinemia/lymphoplasmacytic lymphoma

    Hultcrantz, M., Pfeiffer, R. M., Bjorkholm, M., Goldin, L. R., Ingemar Turesson, Schulman, S., Landgren, O. & Kristinsson, S. Y., 2014, I : Journal of Thrombosis and Haemostasis. 12, 11, s. 1816-1821

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  15. Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti-Xa assays.

    Andreas Hillarp, Gustafsson, K. M., Faxälv, L., Strandberg, K., Baghaei, F., Fagerberg Blixter, I., Berndtsson, M. & Lindahl, T. L., 2014, I : Journal of Thrombosis and Haemostasis. 12, 9, s. 1545-1553

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  16. Definitions in hemophilia: communication from the SSC of the ISTH

    Blanchette, V. S., Key, N. S., Rolf Ljung, Manco-Johnson, M. J., Van Den Berg, H. M. & Srivastava, A., 2014, I : Journal of Thrombosis and Haemostasis. 12, 11, s. 1935-1939

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  17. 40K glycoPEGylated, recombinant FVIIa: 3-month, double-blind, randomized trial of safety, pharmacokinetics, and preliminary efficacy in hemophilia patients with inhibitors.

    Rolf Ljung, Karim, F. A., Saxena, K., Suzuki, T., Arkhammar, P., Rosholm, A. & Giangrande, P., 2013, I : Journal of Thrombosis and Haemostasis. 11, 7, s. 1260-1268

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. Platelet shedding of CD40L is regulated by matrix metalloproteinase-9 in abdominal sepsis.

    Milladur Rahman, Zhang, S., Chew, M., Ingvar Syk, Bengt Jeppsson & Henrik Thorlacius, 2013, I : Journal of Thrombosis and Haemostasis. 11, 7, s. 1385-1398

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  19. Origin of Swedish hemophilia B mutations

    Hallden, C., Annika Mårtensson, Nilsson, D., Torbjörn Säll, Lind-Hallden, C., Liden, A. C. & Rolf Ljung, 2013, I : Journal of Thrombosis and Haemostasis. 11, 11, s. 2001-2008

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. Origin of Swedish hemophilia A mutations

    Halldén, C., Nilsson, D., Torbjörn Säll, Lind-Hallden, C., Liden, A. C. & Rolf Ljung, 2012, I : Journal of Thrombosis and Haemostasis. 10, 12, s. 2503-2511

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  21. Demographic and clinical data in acquired hemophilia a: results from the european acquired haemophilia (each2) registry.

    Knoebl, P., Paese, M., Baudo, F., Collins, P., Huth-Kühne, A., Nemes, L., Pellegrini, F., Lilian Tengborn & Lévesque, H., 2012, I : Journal of Thrombosis and Haemostasis. 10, 4, s. 622-631

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  22. Mortality and Inherited Thrombophilia: results from the European Prospective Cohort on Thrombophilia (EPCOT).

    Pabinger, I., Vossen, C. Y., Lang, J., Conard, J., García-Dabrio, M. C., Miesbach, W., Legnani, C., Peter Svensson, Kaider, A. & Rosendaal, F. R., 2012, I : Journal of Thrombosis and Haemostasis. 10, 2, s. 217-222

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  23. Population pharmacokinetic modeling for dose setting of nonacog beta pegol (N9-GP), a glycoPEGylated recombinant factor IX.

    Collins, P. W., Møss, J., Knobe, K., Groth, A., Colberg, T. & Watson, E., 2012, I : Journal of Thrombosis and Haemostasis. 10, 11, s. 2305-2312

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  24. Endothelial cell protein C receptor-mediated redistribution and tissue-level accumulation of factor VIIa.

    Clark, C. A., Vatsyayan, R., Hedner, U., Esmon, C. T., Pendurthi, U. R. & Rao, L. V. M., 2012, I : Journal of Thrombosis and Haemostasis. 10, 11, s. 2383-2391

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  25. Induction of Auto-Antibodies Against β(2) -Glycoprotein I in Mice by Protein H of Streptococcus Pyogenes.

    van Os, G. M. A., Meijers, J. C. M., Ağar, C., Valls Serón, M., Marquart, J. A., Per Åkesson, Urbanus, R. T., Derksen, R. H. W. M., Heiko Herwald, Mörgelin, M. & de Groot, P. G., 2011, I : Journal of Thrombosis and Haemostasis. 9, 12, s. 2447-2456

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  26. Recombinant human factor VIIa (rFVIIa) cleared principally by antithrombin following IV administration in haemophilia patients.

    Agersø, H., Brophy, D. F., Pelzer, H., Martin, E. J., Carr, M., Hedner, U. & Ezban, M., 2011, I : Journal of Thrombosis and Haemostasis. 9, 2, s. 333-338

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  27. Succinate independently stimulates full platelet activation via cAMP and PI3β kinase signaling.

    Högberg, C., Olof Gidlöf, Tan, C., Svensson, S., Öhman, J., David Erlinge & Björn Olde, 2011, I : Journal of Thrombosis and Haemostasis. 9, 2, s. 361-372

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  28. A Randomized Clinical Trial of Prophylaxis in Children with Hemophilia A (the ESPRIT Study).

    Gringeri, A., Björn Lundin, Mackensen, S. V., Mantovani, L. & Mannucci, P. M., 2011, I : Journal of Thrombosis and Haemostasis. 9, s. 700-710

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  29. Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays.

    Andreas Hillarp, Baghaei, F., Blixter, I. F., Gustafsson, K. M., Stigendal, L., Sten-Linder, M., Strandberg, K. & Lindahl, T. L., 2011, I : Journal of Thrombosis and Haemostasis. 9, s. 133-139

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  30. Safety and pharmacokinetics of subcutaneously administered recombinant activated factor VII (rFVIIa).

    Tiede, A., Friedrich, U., Stenmo, C., Allen, G., Giangrande, P., Goudemand, J., Hay, C., Holmström, E. M., Klamroth, R., Lethagen, S., McKenzie, S., Miesbach, W., Negrier, C., Yuste, V. J. & Erik Berntorp, 2011, I : Journal of Thrombosis and Haemostasis. 9, s. 1191-1199

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  31. Novel APC-cleavage sites in FVa providing insights into mechanisms of action of APC and its cofactor protein S.

    Tran, S. & Björn Dahlbäck, 2010, I : Journal of Thrombosis and Haemostasis. 8, 1, s. 129-136 8 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  32. Bio-distribution of pharmacologically administered recombinant factor VIIa (rFVIIa)

    Gopalakrishnan, R., Hedner, U., Ghosh, S., Nayak, R. C., Allen, T. C., Pendurthi, U. R. & Rao, L. V. M., 2010, I : Journal of Thrombosis and Haemostasis. 8, 2, s. 301-310

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  33. Gas6 is complexed to soluble tyrosine kinase receptor Axl in human blood.

    Carl Ekman, Stenhoff, J. & Björn Dahlbäck, 2010, I : Journal of Thrombosis and Haemostasis. 8, 4, s. 838-844

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  34. Improved performance characteristics of the von Willebrand factor ristocetin cofactor activity assay using a novel automated assay protocol.

    Andreas Hillarp, Stadler, M., Haderer, C., Weinberger, J., Kessler, C. M. & Römisch, J., 2010, I : Journal of Thrombosis and Haemostasis. 8, s. 2216-2223

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  35. The role of phospholipid transfer protein in lipoprotein-mediated neutralization of the procoagulant effect of anionic liposomes.

    Oslakovic, C., Jauhiainen, M., Ehnholm, C. & Björn Dahlbäck, 2010, I : Journal of Thrombosis and Haemostasis. 8, s. 766-772

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  36. Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A

    Collins, P. W., Blanchette, V. S., Fischer, K., Bjorkman, S., Oh, M., Fritsch, S., Schroth, P., Spotts, G., Jan Astermark & Ewenstein, B., 2009, I : Journal of Thrombosis and Haemostasis. 7, 3, s. 413-420

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  37. The activation peptide of thrombin-activatable fibrinolysis inhibitor: a role in activity and stability of the enzyme?

    Marx, P. F., Plug, T., Havik, S. R., Mörgelin, M. & Meijers, J. C. M., 2009, I : Journal of Thrombosis and Haemostasis. 7, 3, s. 445-452

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  38. Does an active sun exposure habit lower the risk of venous thrombotic events? A D-lightful hypothesis

    Lindqvist, P. G., Epstein, E. & Håkan Olsson, 2009, I : Journal of Thrombosis and Haemostasis. 7, 4, s. 605-610

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  39. Impact of polymorphisms of the major histocompatibility complex class II, interleukin-10, tumor necrosis factor-alpha and cytotoxic T-lymphocyte antigen-4 genes on inhibitor development in severe hemophilia A

    Pavlova, A., Delev, D., Lacroix-Desmazes, S., Schwaab, R., Mende, M., Fimmers, R., Jan Astermark & Oldenburg, J., 2009, I : Journal of Thrombosis and Haemostasis. 7, 12, s. 2006-2015

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  40. Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD)

    Budde, U., Schneppenheim, R., Eikenboom, J., Goodeve, A., Will, K., Drewke, E., Castaman, G., Rodeghiero, F., Federici, A. B., Batlle, J., Perez, A., Meyer, D., Mazurier, C., Goudemand, J., Ingerslev, J., Habart, D., Vorlova, Z., Holmberg, L., Lethagen, S., Pasi, J. & 2 andraHill, F. & Peake, I., 2008, I : Journal of Thrombosis and Haemostasis. 6, 5, s. 762-771

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  41. Recombinant human factor VIIa and a factor VIIa-analogue reduces heparin and low molecular weight heparin (LMWH)-induced bleeding in rats

    Lauritzen, B., Hedner, U., Johansen, P. B., Tranholm, M. & Ezban, M., 2008, I : Journal of Thrombosis and Haemostasis. 6, 5, s. 804-811

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  42. Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD)

    Tosetto, A., Rodeghiero, F., Castaman, G., Bernardi, M., Bertoncello, K., Goodeve, A., Federici, A. B., Batlle, J., Meyer, D., Mazurier, C., Goudemand, J., Eikenboom, J., Schneppenheim, R., Budde, U., Ingerslev, J., Vorlova, Z., Habart, D., Holmberg, L., Lethagen, S., Pasi, J. & 2 andraHill, F. & Peake, I., 2007, I : Journal of Thrombosis and Haemostasis. 5, 4, s. 715-721

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  43. Von Willebrand factor/factor VIII concentrate (Haemate(R) P) dosing based on pharmacokinetics: a prospective multicenter trial in elective surgery.

    Lethagen, S., Kyrle, P. A., Castaman, G., Haertel, S. & Mannucci, P. M., 2007, I : Journal of Thrombosis and Haemostasis. 5, Apr 16, s. 1420-1430

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  44. Treatment of severe von Willebrand disease with a high-purity von Willebrand factor concentrate (Wilfactin (R)): a prospective study of 50 patients

    Borel-Derlon, A., Federici, A. B., Roussel-Robert, V., Goudemand, J., Lee, C. A., Scharrer, I., Rothschild, C., Erik Berntorp, Henriet, C., Tellier, Z., Bridey, F. & Mannucci, P. M., 2007, I : Journal of Thrombosis and Haemostasis. 5, 6, s. 1115-1124

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  45. Polymorphisms in the CTLA-4 gene and inhibitor development in patients with severe hemophilia A

    Jan Astermark, Wang, X., Oldenburg, J., Erik Berntorp & Lefvert, A. -K., 2007, I : Journal of Thrombosis and Haemostasis. 5, 2, s. 263-265

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  46. Systemic administration of anti-urokinase plasminogen activator receptor monoclonal antibodies induces hepatic fibrin deposition in tissue-type plasminogen activator deficient mice

    Annika Jögi, Pass, J., Hoyer-Hansen, G., Lund, L. R., Nielsen, B. S., Dano, K. & Romer, J., 2007, I : Journal of Thrombosis and Haemostasis. 5, 9, s. 1936-1944

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  47. Potential role of rFVIIa in prophylaxis in severe haemophilia patients with inhibitors.

    Hedner, U., 2006, I : Journal of Thrombosis and Haemostasis. 4, Aug 14, s. 2498-2500

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  48. Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand disease: an international, multicenter study

    Castaman, G., Rodeghiero, F., Tosetto, A., Cappelletti, A., Baudo, F., Eikenboom, J. C. J., Federici, A. B., Lethagen, S., Linari, S., Lusher, J., Nishino, M., Petrini, P., Srivastava, A. & Ungerstedt, J. S., 2006, I : Journal of Thrombosis and Haemostasis. 4, 10, s. 2164-2169

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  49. The lectin-like domain of thrombomodulin interferes with complement activation and protects against arthritis

    Van de Wouwer, M., Plaisance, S., De Vriese, A., Waelkens, E., Collen, D., Jenny J Persson, Daha, M. R. & Conway, E. M., 2006, I : Journal of Thrombosis and Haemostasis. 4, 8, s. 1813-1824

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  50. Incidence and risk of venous thromboembolism in patients with verified arterial thrombosis: a population study based on 23 796 consecutive autopsies

    Eliasson, A., Bergqvist, D., Bjorck, M., Stefan Acosta, Sternby, N. & Ogren, M., 2006, I : Journal of Thrombosis and Haemostasis. 4, 9, s. 1897-1902

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  51. Activated protein C resistance - in the absence of factor V Leiden - and pregnancy.

    Lindqvist, P. G., Svensson, P. & Björn Dahlbäck, 2006, I : Journal of Thrombosis and Haemostasis. 4, 2, s. 361-366

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  52. From gamma-carboxy-glutamate to protein C.

    Johan Stenflo, 2006, I : Journal of Thrombosis and Haemostasis. 4, 12, s. 2521-2526

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  53. Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD

    Eikenboom, J., Van Marion, V., Putter, H., Goodeve, A., Rodeghiero, F., Castaman, G., Federici, AB., Batlle, J., Meyer, D., Mazurier, C., Goudemand, J., Schneppenheim, R., Budde, U., Ingerslev, J., Vorlova, Z., Habart, D., Holmberg, L., Lethagen, S., Pasi, J., Hill, F. & 1 andraPeake, I., 2006, I : Journal of Thrombosis and Haemostasis. 4, 4, s. 774-782

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  54. The von Willebrand disease prophylaxis network: exploring a treatment concept.

    Erik Berntorp & Abshire, T., 2006, I : Journal of Thrombosis and Haemostasis. 4, 11, s. 2511-2512

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  55. A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD)

    Tosetto, A., Rodeghiero, F., Castaman, G., Goodeve, A., Federici, AB., Batlle, J., Meyer, D., Fressinaud, E., Mazurier, C., Goudemand, J., Eikenboom, J., Schneppenheim, R., Budde, U., Ingerslev, J., Vorlova, Z., Habart, D., Holmberg, L., Lethagen, S., Pasi, J., Hill, F. & 1 andraPeake, I., 2006, I : Journal of Thrombosis and Haemostasis. 4, 4, s. 766-773

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  56. The cleaved and latent forms of antithrombin are normal constituents of blood plasma: a quantitative method to measure cleaved antithrombin.

    Kjellberg, M., Ikonomou, T. & Johan Stenflo, 2006, I : Journal of Thrombosis and Haemostasis. 4, 1, s. 168-176

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  57. Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT)

    Vossen, CY., Conard, J., Fontcuberta, J., Makris, M., Van der Meer, FJM., Pabinger, I., Palareti, G., Preston, FE., Scharrer, I., Souto, JC., Peter Svensson, Walker, ID. & Rosendaal, FR., 2005, I : Journal of Thrombosis and Haemostasis. 3, 3, s. 459-464

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  58. Soluble thrombomodulin activity and soluble thrombomodulin antigen in plasma.

    Öhlin, A-K., Larsson, K. & Hansson, M., 2005, I : Journal of Thrombosis and Haemostasis. 3, 5, s. 976-982

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  59. Factor H binds to washed human platelets.

    Vaziri-Sani, F., Hellwage, J., Zipfel, P. F., Sjöholm, A., Iancu, R. & Diana Karpman, 2005, I : Journal of Thrombosis and Haemostasis. 3, 1, s. 154-162

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  60. Genetic analysis of 31 Swedish type 1 von Willebrand disease families reveals incomplete linkage to the von Willebrand factor gene and a high frequency of a certain disease haplotype.

    Lanke, E., Johansson, A., Halldén, C. & Lethagen, S., 2005, I : Journal of Thrombosis and Haemostasis. 3, 12, s. 2656-2663

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  61. The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study

    Rodeghiero, F., Castaman, G., Tosetto, A., Batlle, J., Baudo, F., Cappelletti, A., Casana, P., De Bosch, N., Eikenboom, JCJ., Federici, AB., Lethagen, S., Linari, S. & Srivastava, A., 2005, I : Journal of Thrombosis and Haemostasis. 3, 12, s. 2619-2626

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  62. Pharmacokinetic studies on Wilfactin((R)), a von Willebrand factor concentrate with a low factor VIII content treated with three virus-inactivation/removal methods

    Goudemand, J., Scharrer, I., Erik Berntorp, Lee, CA., Borel-Derlon, A., Stieltjes, N., Caron, C., Scherrmann, JM., Bridey, F., Tellier, Z., Federici, AB. & Mannucci, PM., 2005, I : Journal of Thrombosis and Haemostasis. 3, 10, s. 2219-2227

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  63. Co-segregation of the PROS1 locus and protein S deficiency in families having no detectable mutations in PROS1.

    Lanke, E., Johansson, A., Andreas Hillarp, Lethagen, S., Bengt Zöller, Björn Dahlbäck & Halldén, C., 2004, I : Journal of Thrombosis and Haemostasis. 2, 11, s. 1918-1923

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  64. Familial thrombophilia and lifetime risk of venous thrombosis

    Vossen, CY., Conard, J., Fontcuberta, J., Makris, M., Van Der Meer, FJM., Pabinger, I., Palareti, G., Preston, FE., Scharrer, I., Souto, JC., Peter Svensson, Walker, ID. & Rosendaal, FR., 2004, I : Journal of Thrombosis and Haemostasis. 2, 9, s. 1526-1532

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  65. Hereditary thrombophilia and fetal loss: a prospective follow-up study

    Vossen, CY., Preston, FE., Conard, J., Fontcuberta, J., Makris, M., Van Der Meer, FJM., Pabinger, I., Palareti, G., Scharrer, I., Souto, JC., Peter Svensson, Walker, ID. & Rosendaal, FR., 2004, I : Journal of Thrombosis and Haemostasis. 2, 4, s. 592-596

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  66. Transcriptional down-regulation of the platelet ADP receptor P2Y(12) and clusterin in patients with systemic lupus erythematosus.

    Wang, L., Erling, P., Anders Bengtsson, Lennart Truedsson, Sturfelt, G. & David Erlinge, 2004, I : Journal of Thrombosis and Haemostasis. 2, 8, s. 1436-1442

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  67. Thrombosis in inherited factor VII deficiency.

    Mariani, G., Herrmann, F. H., Schulman, S., Batorova, A., Wulff, K., Etro, D., Dolce, A., Auerswald, G., Jan Astermark, Schved, J-F., Ingerslev, J. & Bernardi, F., 2003, I : Journal of Thrombosis and Haemostasis. 1, 10, s. 2153-2158

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  68. Functional analysis of the EGF-like domain mutations Pro55Ser and Pro55Leu, which cause mild hemophilia B.

    Knobe, K., Kristina Persson, Sjörin, E., Villoutreix, B. O., Johan Stenflo & Rolf Ljung, 2003, I : Journal of Thrombosis and Haemostasis. 1, 4, s. 782-790

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  69. The discovery of activated protein C resistance.

    Björn Dahlbäck, 2003, I : Journal of Thrombosis and Haemostasis. 1, 1, s. 3-9

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  70. Molecular recognition in the protein C anticoagulant pathway.

    Björn Dahlbäck & Villoutreix, B. O., 2003, I : Journal of Thrombosis and Haemostasis. 1, 7, s. 1525-1534

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  71. Anti-factor V auto-antibody in the plasma and platelets of a patient with repeated gastrointestinal bleeding

    Ajzner, E., Balogh, I., Haramura, G., Boda, Z., Kalmar, K., Pfliegler, G., Björn Dahlbäck & Muszbek, L., 2003, I : Journal of Thrombosis and Haemostasis. 1, 5, s. 943-949

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  72. The role of recombinant factor VIIa(FVIIa) in fibrin structure in the absence of FVIII/FIX

    He, S., Blomback, M., Ekman, GJ. & Hedner, U., 2003, I : Journal of Thrombosis and Haemostasis. 1, 6, s. 1215-1219

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  73. Quantification of ADP and ATP receptor expression in human platelets.

    Wang, L., Ostberg, O., Anna-Karin Wihlborg, Brogren, H., Jern, S. & David Erlinge, 2003, I : Journal of Thrombosis and Haemostasis. 1, 2, s. 330-336

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  74. Fresh frozen plasma reduces thrombin formation in newborn infants

    Hyytiainen, S., Syrjala, M., Vineta Fellman, Heikinheimo, M. & Petaja, J., 2003, I : Journal of Thrombosis and Haemostasis. 1, 6, s. 1189-1194

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  75. Monitoring the bioavailability of FEIBA with a thrombin generation assay

    Varadi, K., Negrier, C., Erik Berntorp, Jan Astermark, Bordet, JC., Morfini, M., Linari, S., Schwarz, HP. & Turecek, PL., 2003, I : Journal of Thrombosis and Haemostasis. 1, 11, s. 2374-2380

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  76. Letter
  77. Exposure to factor VIII and prediction of inhibitor development: exposure days vs. danger days, or both?

    Hermans, C., Jan Astermark & De Moerloos, P., 2012, I : Journal of Thrombosis and Haemostasis. 10, 10, s. 2194-2196

    Forskningsoutput: TidskriftsbidragLetter

  78. Influence of endothelial cell protein C receptor on plasma clearance of factor VIIa.

    Gopalakrishnan, R., Pendurthi, U. R., Hedner, U., Agersø, H., Esmon, C. T. & Rao, L. V. M., 2012, I : Journal of Thrombosis and Haemostasis. 10, 5, s. 971-973

    Forskningsoutput: TidskriftsbidragLetter

  79. Family history of venous thromboembolism is associated with increased risk for thrombosis in multiple myeloma: a population-based study.

    Kristinsson, S. Y., Goldin, L., Ingemar Turesson, Hultcrantz, M., Björkholm, M. & Landgren, O., 2012, I : Journal of Thrombosis and Haemostasis. 10, 5, s. 962-964

    Forskningsoutput: TidskriftsbidragLetter

  80. rFVIIa transported from the blood stream into tissues is functionally active

    Gopalakrishnan, R., Hedner, U., Clark, C., Pendurthi, U. R. & Rao, L. V. M., 2010, I : Journal of Thrombosis and Haemostasis. 8, 10, s. 2318-2321

    Forskningsoutput: TidskriftsbidragLetter

  81. Influence of endotoxin challenge on protein S and C4b-binding protein in healthy subjects

    Krabbe, KS., Bruunsgaard, H., Andreas Hillarp & Thorsen, S., 2006, I : Journal of Thrombosis and Haemostasis. 4, 3, s. 692-694

    Forskningsoutput: TidskriftsbidragLetter

  82. Low molecular weight heparin for repeated pregnancy loss: is it based on solid evidence?

    Lindqvist, P. G. & Juan Merlo, 2005, I : Journal of Thrombosis and Haemostasis. 3, 2, s. 221-223

    Forskningsoutput: TidskriftsbidragLetter

  83. Guidelines on preparation, certification, and use of certified plasmas for ISI calibration and INR determination - a rebuttal

    Egberg, N., Fagerberg, I., Andreas Hillarp, Lindahl, TL. & Stigendal, L., 2005, I : Journal of Thrombosis and Haemostasis. 3, 10, s. 2370-2371

    Forskningsoutput: TidskriftsbidragLetter

  84. The multiple faces of the partial thromboplastin time APTT.

    Björn Dahlbäck, 2004, I : Journal of Thrombosis and Haemostasis. 2, 12, s. 2256-2257

    Forskningsoutput: TidskriftsbidragLetter

  85. Etonogestrel implant use is not related to hypercoagulable changes in anticoagulant system.

    Lindqvist, P. G., Rosing, J., Malmquist, A. & Andreas Hillarp, 2003, I : Journal of Thrombosis and Haemostasis. 1, 3, s. 601-602

    Forskningsoutput: TidskriftsbidragLetter

  86. Debate/Note/Editorial
  87. Family secrets to be disclosed.

    Lindqvist, P. G. & Joyce Carlson, 2006, I : Journal of Thrombosis and Haemostasis. 4, 10, s. 2180-2181

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  88. Are randomized clinical trials the only truth? Not always

    Aledort, L., Rolf Ljung & Blanchette, V., 2006, I : Journal of Thrombosis and Haemostasis. 4, 3, s. 503-504

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  89. Desmopressin (DDAVP) and factor VIII

    Lars Holmberg, 2003, I : Journal of Thrombosis and Haemostasis. 1, 9, s. 2046-2047

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  90. Publicerat konferensabstract
  91. Thirty-years' experience of prenatal diagnosis of haemophilia in Sweden

    R. Ljung & ANNIKA MÅRTENSSON, 2011 jul 1, I : Journal of Thrombosis and Haemostasis. 9, s. 462 1 s., P-TU-492.

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

Föregående 1 2 Nästa